Novabay pharmaceuticals, inc. (NBY)
Balance Sheet / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Dec'10
ASSETS
Cash and cash equivalents

5,708

6,937

9,020

3,668

2,932

3,183

5,207

6,833

8,336

3,199

6,076

5,722

7,399

9,512

9,430

3,495

1,430

2,385

3,383

7,208

5,598

5,429

7,884

7,757

10,316

10,500

6,934

6,594

8,387

12,735

7,219

4,653

6,121

8,428

12,430

7,973

11,534

Short-term investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,251

3,808

4,858

2,553

3,885

4,811

4,805

4,135

4,663

5,720

5,232

5,710

2,241

1,288

1,272

Accounts receivable, net of allowance for doubtful accounts ($50 and $51 at March 31, 2020 and December 31, 2019, respectively)

952

1,066

1,505

1,536

2,430

3,385

2,612

2,024

2,225

3,629

2,230

3,601

2,331

2,120

2,079

1,490

1,497

536

543

389

283

273

364

440

260

784

272

112

916

943

126

9

1,009

3

1,825

3,566

500

Inventory, net of allowance for excess and obsolete inventory and lower of cost or estimated net realizable value adjustments ($230 and $247 at March 31, 2020 and December 31, 2019, respectively)

552

492

838

664

302

280

390

317

479

504

599

672

765

873

1,084

1,115

1,201

1,345

-

-

-

521

405

218

155

-

63

48

61

23

-

-

-

-

-

-

-

Prepaid expenses and other current assets

662

886

1,135

1,628

1,451

1,760

1,319

1,598

1,751

1,663

1,033

972

-

1,966

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Inventory

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,583

1,452

492

-

-

-

-

70

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

-

-

-

-

-

-

-

-

-

-

-

-

1,036

-

1,827

474

433

261

668

597

1,223

729

514

656

794

884

330

427

365

445

508

506

427

417

289

586

448

Total current assets

7,874

9,381

12,498

7,496

7,115

8,608

9,528

10,772

12,791

8,995

9,938

10,967

11,531

14,471

14,420

6,574

4,561

4,527

6,177

9,646

7,596

6,952

10,418

12,879

16,383

14,791

11,484

11,992

14,534

18,281

12,516

10,888

12,789

14,558

16,785

13,413

13,754

Operating lease right-of-use assets

1,028

1,252

1,435

1,655

1,870

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Property and equipment, net

97

110

128

177

193

201

271

351

435

471

492

462

421

371

282

366

370

395

359

375

408

436

478

488

658

718

687

761

819

891

1,037

1,069

1,148

1,270

1,372

1,475

1,588

Other assets

476

477

542

542

542

552

566

582

597

613

626

641

730

539

439

65

0

155

154

153

151

149

147

146

144

141

74

74

63

63

117

117

105

135

144

148

174

TOTAL ASSETS

9,475

11,220

14,603

9,870

9,720

9,361

10,365

11,705

13,823

10,079

11,056

12,070

12,682

15,381

15,141

7,005

4,931

5,077

6,690

10,174

8,155

7,537

11,043

13,513

17,185

15,650

12,245

12,827

15,416

19,235

13,670

12,074

14,042

15,963

18,301

15,036

15,516

LIABILITIES AND STOCKHOLDERS' (DEFICIT) EQUITY
Accounts payable

602

331

503

356

462

551

564

329

301

466

356

908

798

455

387

860

1,820

2,483

2,870

1,777

2,178

1,865

918

520

487

1,674

1,013

611

539

455

1,051

901

439

472

320

448

406

Accrued liabilities

1,326

1,778

1,642

1,931

2,860

3,255

2,751

2,665

2,855

1,672

2,419

1,655

1,831

2,007

1,880

1,915

2,019

1,980

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

559

-

-

-

-

41

62

62

62

75

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease liability

774

930

1,058

1,065

1,073

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Notes payable, related party

1,250

1,202

1,155

-

1,019

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Convertible note

954

1,409

1,890

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Embedded derivative liability

1

3

4

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Warrant liability

17

34

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,006

764

1,095

1,055

1,176

1,301

1,595

1,616

1,842

1,708

1,178

1,497

1,572

1,306

1,161

1,061

631

961

726

Equipment loan

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

106

Deferred revenue

-

-

-

-

-

-

-

-

-

-

2,487

2,172

1,673

1,861

1,461

1,593

189

170

378

220

425

425

259

196

200

337

207

470

757

1,221

1,409

1,537

1,334

1,305

1,813

2,306

1,485

Total current liabilities

5,483

5,687

6,252

3,352

5,414

3,847

3,377

3,056

3,218

4,979

5,262

4,735

4,302

4,323

3,728

4,368

4,028

4,633

4,254

2,761

3,698

3,345

2,353

2,017

2,282

3,627

3,062

2,789

2,474

3,173

4,032

3,744

2,934

2,838

3,985

3,715

2,723

Operating lease liabilities-non-current

406

505

627

889

1,143

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenues - non-current

-

-

-

-

-

-

0

0

0

534

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenues - non-current

-

-

-

-

-

-

-

-

-

-

1,569

1,997

1,807

1,986

1,913

2,132

3,115

2,248

2,022

2,189

1,993

2,000

2,212

1,601

1,605

1,534

1,081

1,037

730

671

208

539

869

945

1,260

1,575

2,204

Deferred rent

-

-

-

-

-

184

213

237

261

286

286

300

314

327

248

189

189

189

187

181

176

171

164

155

145

136

116

93

73

60

67

50

115

115

113

109

99

Warrant liability

3,935

4,055

-

-

-

178

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term

-

-

-

1,110

-

-

-

-

-

-

-

-

-

-

0

524

3,063

1,655

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Warrant liability

-

-

3,902

266

179

-

518

785

1,275

1,489

1,889

1,608

1,681

1,446

2,336

2,259

1,834

1,450

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Convertible note

-

-

-

1,654

1,227

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Embedded derivative liability

-

-

-

673

427

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other liabilities

-

-

315

257

201

198

198

198

198

197

218

221

222

198

198

-

-

0

-

139

139

173

624

520

-

1,837

-

-

-

-

-

-

-

-

-

-

-

Warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,317

-

2,564

1,698

1,802

1,282

1,919

2,128

2,756

2,721

1,221

-

-

Total liabilities

9,824

10,247

11,096

8,201

8,591

4,407

4,306

4,276

4,952

7,485

9,224

8,861

8,326

8,280

8,423

9,472

12,230

10,175

6,463

5,270

6,006

5,689

5,353

4,293

5,349

7,134

6,823

5,617

5,079

5,186

6,226

6,461

6,674

6,619

5,358

5,399

5,026

Series A non-voting convertible preferred stock, $0.01 par value; 2,700 shares authorized; 2,700 and 0 shares issued and outstanding at September 30, 2019 and December 31, 2018, respectively

-

-

584

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Commitments and Contingencies (Note 9)

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

Stockholders' (deficit) equity:
Preferred stock: 5,000 shares authorized; none issued and outstanding at March 31, 2020 and December 31, 2019

-

-

-

0

0

-

0

0

0

0

0

0

0

0

-

-

-

0

0

0

0

0

0

0

0

0

0

0

0

0

-

0

0

0

0

-

-

Common stock, $0.01 par value; 50,000 shares authorized; 28,239 and 27,938 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively

282

279

252

207

171

171

171

171

171

154

154

153

153

153

149

92

51

35

746

736

611

21

511

508

507

446

387

374

369

369

297

289

288

286

283

235

234

Additional paid-in capital

125,975

125,718

125,009

123,518

120,484

119,764

119,601

119,433

119,285

113,514

113,545

112,477

111,885

110,619

108,592

95,728

88,248

85,387

85,797

85,242

77,725

73,374

72,267

71,586

71,260

64,438

57,264

55,223

54,299

54,004

45,137

43,427

42,937

42,386

42,325

39,168

38,469

Accumulated other comprehensive loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

-9

-13

-13

-15

-13

-19

-11

-13

-29

-62

-42

-44

-9

-4

-14

Accumulated deficit

-126,606

-125,024

-122,338

-122,056

-119,526

-114,981

-113,713

-112,175

-110,585

-111,074

-111,867

-109,421

-107,682

-103,671

-102,023

-98,287

-95,598

-90,520

-86,316

-81,074

-

-71,547

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total stockholders' (deficit) equity

-349

973

2,923

1,669

1,129

4,954

-

-

-

2,594

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accumulated deficit during development stage

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

76,187

-

67,079

62,861

59,918

56,353

52,216

48,368

44,320

40,311

37,961

38,041

35,815

33,284

29,656

29,762

28,199

Total stockholders' equity

-

-

-

-

-

-

6,059

7,429

8,871

-

1,832

3,209

4,356

7,101

6,718

-2,467

-7,299

-5,098

227

4,904

2,149

1,848

5,690

9,220

11,836

8,516

5,422

7,210

10,337

14,049

7,444

5,613

7,368

9,344

12,943

9,637

10,490

TOTAL LIABILITIES AND STOCKHOLDERS' (DEFICIT) EQUITY

9,475

11,220

14,603

9,870

9,720

9,361

10,365

11,705

13,823

10,079

11,056

12,070

12,682

15,381

15,141

7,005

4,931

5,077

6,690

10,174

8,155

7,537

11,043

13,513

17,185

15,650

12,245

12,827

15,416

19,235

13,670

12,074

14,042

15,963

18,301

15,036

15,516

Previously Reported [Member]
Deferred revenue

-

-

-

-

-

-

-

-

-

2,841

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-